Patent details
LUC50048
Product Name:
Vaccin polysaccharidique pneumococcique conjugué comprenant les sérotypes polysaccharidiques pneumococciques 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, deOAc15B (sérotype 15B dés-O-acétylé), 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F et 35B, dans lequel les sérotypes sont conjugués à la protéine porteuse CRM197
Basic Information
- Publication number:
- LUC50048
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
-
EP188718258
- Legal Status:
- Pending & Published
- Application number:
- LUC50048
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/25/1913
- Marketing Authorization Type:
-
- Marketing Authorization Date:
- 25/03/2025
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 07/04/2026
- First Marketing Authorization date:
- 25/03/2025
- Grant date:
- Activation date:
- Publication date:
- 07/04/2026
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 25/03/2040
- SPC Extension Expiration:
- 25/03/2040
- Rejection date:
- Withdrawal date:
Owner
- From:
- 07/04/2026
-
-
- Name:
- Merck Sharp & Dohme LLC
- Address:
- 126 East Lincoln Avenue, Rahway, New Jersey 07065, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 07/04/2026
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Publication
Bulletin
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2026/06
- Publication date:
- 04/05/2026
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
Annual Fees
- Annual Fee Due Date:
- 31/12/2038
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-